High MDM4 levels are likely to be selected at early disease stage in PC to keep wt p53 tumour-suppressive activities in check, particularly in response to intra- and extra-cellular stress signals, such as oncogenic events (i.e., loss of PTEN) and inflammation (e.g., [55]). This evidence concerns the gene MDM4 and neoplasm.